ALLIANCEBERNSTEIN L.P.

Position in HROW — Harrow, Inc.

CIK 1109448 NASHVILLE, TN

Position in HROW

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,045,000

-$401,480 QoQ

Shares Held

29,637

+0.4% QoQ

Ownership

0.080%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ALLIANCEBERNSTEIN L.P. holds $800,528,984 across 41 Drug Manufacturers - Specialty & Generic names. HROW ranks #25 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	3,633,318	$429,494,520
2	UTHR	UNITED THERAPEUTICS Corp	220,634	$130,831,549
3	NBIX	Neurocrine Biosciences Inc	523,533	$68,970,237
4	RDY	Dr Reddys Laboratories Ltd	2,541,889	$35,205,162
5	KNSA	Kiniksa Pharmaceuticals International, plc	598,888	$28,836,457
6	VTRS	Viatris Inc	1,229,714	$16,613,436
7	ELAN	Elanco Animal Health Inc	624,049	$14,933,492
8	HIMS	Hims & Hers Health, Inc.	501,138	$10,403,624

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,045,000	29,637	+0.4%	Shares	Defined	2026-05-15
2025-12-31	$1,446,480	29,520	0.0%	Shares	Defined	2026-02-17
2025-09-30	$1,422,273	29,520	+1.7%	Shares	Defined	2025-11-14
2025-06-30	$886,270	29,020	0.0%	Shares	Defined	2025-08-14
2025-03-31	$771,932	29,020	0.0%	Shares	Defined	2025-05-15
2024-12-31	$973,621	29,020	0.0%	Shares	Defined	2025-02-12
2024-09-30	$1,304,739	29,020	0.0%	Shares	Defined	2024-11-14
2024-06-30	$606,227	29,020	+47.4%	Shares	Defined	2024-08-14
2024-03-31	$260,498	19,690	-17.3%	Shares	Defined	2024-05-14
2023-12-31	$266,784	23,820	+28.1%	Shares	Defined	2024-02-14
2023-09-30	$267,138	18,590	+41.2%	Shares	Defined	2023-11-14
2023-06-30	$250,756	13,170	—	Shares	Defined	2023-08-15
No filing history on record for this holder in this stock.